In Sydney yesterday morning, Allergan officially launched into Australia a new addition to their Juvéderm® filler family. Juvéderm® VOLITE™, which is available now, was introduced for the first time to a selection of media and industry professionals at an exclusive breakfast event and sit-down education session.
The seminar was led by three industry leaders, including leading plastic surgeon Dr Steven Liew, specialist Dermatologist Dr Cara McDonald and renowned aesthetic physician Dr Joseph Hkeik. Drs Hkeik and Liew had been trialling the new Juvéderm® VOLITE™ product on their own patients and were able to present some of their results to attendees, along with other key insights into their respective fields of specialty, including Dr McDonald’s masterclass on skin anatomy and the use of hyaluronic acid.
Juvéderm® VOLITE™ has been designed for the improvement of skin quality, predominantly hydration and elasticity, in addition to the treatment of fine lines. It can be used to treat the face, neck and décolletage, and is administered through multiple shallow injections into the skin with one treatment – taking around 20 minutes. Improvement in texture and dermal hydration is said to last clients around 9 months. Before and after imaging displayed at the media showcase demonstrated some impressive results after just one treatment, including noticeable increases in radiance, texture and overall ‘glow’.
Composed of purified synthesised hyaluronic acid, the new filler uses VYCROSS™ technology, in which chains of HA are crosslinked with 1,4-butanediol diglycidyl ether (BDDE), producing a tight network of HA chains, which increases resistance to degradation, improving durability and biocompatibility of the gel.
Leading Australian Plastic Surgeon Dr Steven Liew says; “We are living in a flawless skin world where everyone is under substantial pressure to maintain peak skin condition, which requires significant time, money and effort. In Australia our environment makes hydration of the skin particularly challenging. Therefore, having options to help support this is very important.”
Specialist Dermatologist Dr Cara McDonald adds, “As a dermatologist, I am constantly seeing women and men who are significantly concerned with their skin. Notably, uneven skin texture and acne scarring, which can have a negative effect on quality of life and can cause low self-esteem.”
The new product development comes as a response to Allergan’s latest independent research, in which insights emphasise the high interest and prioritisation of skin quality among Australians. A recent consumer survey of 3000 Australian men and women (18-65) found that most common skin concerns amongst women were uneven skin complexion (35%), fine lines and wrinkles (34%) and acne scarring (19%). Half (50%) of the respondents with concerns about fine lines and wrinkles said they would consider professional treatment for these issues.
Allergan representatives also emphasised education as one of the company’s main new focuses in Australia moving forward, introducing media to three new priority steps that consumers should be taking before undergoing aesthetic medical procedures. These include ‘Check It’, encouraging qualification checks on chosen practitioners, ‘See It’, which tells consumers to check the name of the product before treatment, and ‘Find It’, pertaining to checking clinic and practitioner licencing and registration details prior to treatment.
Allergan also confirmed that a new product would be released ‘year on year’ in order to keep up with demand and competition, so stay tuned for the next fresh new release in 2020!
For more news and updates, subscribe to our weekly newsletter.